Formulation and Characterization of Intranasal Mucoadhesive Gel of Antiallergic Drug Loratadine for Improved Bioavailability

Authors

  • Shivani Arora Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india
  • Khusi Chouksey Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india
  • Trapti Shrivastava Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india
  • Kuldeep Ganju Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Abstract

The present study aimed to formulate and characterize an intranasal mucoadhesive gel of loratadine to enhance its bioavailability. Loratadine, an antihistamine, is commonly used for the treatment of allergic conditions, but its low bioavailability due to extensive first-pass metabolism can limit its effectiveness. To address this issue, an in situ gel formulation was developed using Poloxamer 407 and Carbopol 934 as excipients. The gel's physicochemical properties, including pH, drug content, viscosity, gel strength, gelation temperature, and drug release profile, were evaluated. FT-IR analysis revealed no significant chemical interaction between the drug and excipients, confirming the stability of the formulation. The gel exhibited shear-thinning behavior and gelation temperatures suitable for nasal administration. In vitro drug release studies showed a sustained release profile, with higher Carbopol concentrations resulting in slower drug release. The mucoadhesion time increased with Carbopol 934 concentration, ensuring prolonged retention at the nasal site. Stability studies demonstrated that the formulations remained stable under standard storage conditions. The results suggest that the loratadine-loaded mucoadhesive gel has the potential to improve the bioavailability of loratadine through intranasal delivery, offering a promising alternative to conventional oral dosage forms.

Keywords: Loratadine, Mucoadhesive Gel, Poloxamer 407, Carbopol 934, In Situ Gel, Bioavailability, Drug Release, Nasal Delivery, Stability, FT-IR

Keywords:

Loratadine, Mucoadhesive Gel, Poloxamer 407, Carbopol 934, In Situ Gel, Bioavailability, Drug Release, Nasal Delivery, Stability, FT-IR

DOI

https://doi.org/10.22270/jddt.v15i1.6952

Author Biographies

Shivani Arora, Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Khusi Chouksey, Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Trapti Shrivastava, Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Kuldeep Ganju, Sagar Institute of Pharmacy & Technology (SIPTec), Bhopal (M.P.), india

Shivani Arora*, Khusi Chouksey, Trapti Shrivastava, Dr. Kuldeep Ganju

References

1. Dewangan HK, Sharma A, Mishra A, Singour P, Mucoadhesive microspheres of Atorvastatin calcium: Rational design, evaluation and enhancement of bioavailability, Indian Journal of Pharmaceutical Education and Research, 2021; 55: 733-741. https://doi.org/10.5530/ijper.55.3s.180

2. Kempwade A, Taranalli A, Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of Rizatriptan benzoate, Journal of Sol-Gel Science and Technology, 2014; 72: 43-48. https://doi.org/10.1007/s10971-014-3422-5

3. Ku MS, Kuo YC, Development and characterization of mucoadhesive gels for intranasal delivery of loratadine, Journal of Drug Delivery Science and Technology, 2014; 24: 389-395.

4. Mua SF, Vudathala SK, Mucoadhesive nasal gel formulations: Recent advances and challenges, International Journal of Pharmaceutics, 2018; 535: 54-63. https://doi.org/10.1016/j.ejpb.2017.10.008 PMid:29032194

5. Rojas JF, Siegel RA, Nasal drug delivery systems: From formulation to clinical trials, Pharmaceutical Development and Technology, 2013; 18: 539-544.

6. Sander M, Grierson C, Nasal drug delivery: A review of current trends and future perspectives, Drug Development and Industrial Pharmacy, 2012; 38:835-843.

7. Schmolka IR, Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burns, Journal of Biomedical Materials Research, 1972; 6: 571-582. https://doi.org/10.1002/jbm.820060609 PMid:4642986

8. Guideline, ICH harmonised tripartite, Stability Testing of New Drug Substances and Products, Q1a, (R2), 2003; Current Step 4.

Published

15-01-2025
Statistics
Abstract Display: 43
PDF Downloads: 31
PDF Downloads: 5

How to Cite

1.
Arora S, Chouksey K, Shrivastava T, Ganju K. Formulation and Characterization of Intranasal Mucoadhesive Gel of Antiallergic Drug Loratadine for Improved Bioavailability. J. Drug Delivery Ther. [Internet]. 2025 Jan. 15 [cited 2025 Feb. 13];15(1):67-72. Available from: https://jddtonline.info/index.php/jddt/article/view/6952

How to Cite

1.
Arora S, Chouksey K, Shrivastava T, Ganju K. Formulation and Characterization of Intranasal Mucoadhesive Gel of Antiallergic Drug Loratadine for Improved Bioavailability. J. Drug Delivery Ther. [Internet]. 2025 Jan. 15 [cited 2025 Feb. 13];15(1):67-72. Available from: https://jddtonline.info/index.php/jddt/article/view/6952